Aemetis, Inc. (AMTX) AI Stock Analysis

Aemetis, Inc. is a renewable energy company operating in North America and India across three primary segments: California Ethanol, Dairy Renewable Natural Gas, and India Biodiesel. The company develops and commercializes technologies designed to lower carbon intensity and replace conventional petroleum fuels. Its portfolio includes biodiesel sold to government oil marketing companies, transport firms, resellers, and refiners, as well as ethanol and by-products like wet distillers grains, distillers corn oil, and condensed distillers solubles for animal feed. Aemetis also produces dairy biogas, high-grade alcohol, hand sanitizers, and conducts research converting waste feedstocks into biofuels.

Aemetis recorded a 5-year revenue CAGR of 4.7% from FY2020 to FY2025. Annual revenue moved from $211.9M in FY2021 to $256.5M in FY2022, dropped to $186.7M in FY2023, rebounded to $267.6M in FY2024, and declined 22.3% to $208.0M in FY2025. Operating margins remained negative across that period, reaching -17.9% in FY2025 alongside net income of -$77.0M. For the trailing twelve months ended June 30, 2026, revenue stood at $230.2M with a profit margin of -26.1% and an operating margin of 9.2%. In the latest quarter ended June 30, 2026, quarterly revenue increased 20.0% year-over-year.

As of June 30, 2026, Aemetis held $973,000 in cash and short-term investments against $419.9M in total debt, resulting in net debt of $418.9M. Total assets were $289.2M, and shareholders' equity was -$322.1M, reflecting negative equity. The company reported a current ratio of 0.08. In FY2025, operating cash flow was $3.3M, free cash flow was -$22.7M, and capital expenditures totaled $26.0M. Over 5 years, the company's share count increased by 113.2%.

Aemetis has an enterprise value of $552.0M and a market capitalization of $105.4M. Its forward price-to-earnings ratio is 58.8x, compared to 13.4x for the median of its US-listed Basic Materials peers. The stock trades at a price-to-sales multiple of 0.5x, below the peer group median of 1.8x, and an EV-to-revenue ratio of 2.4x. Over the past year, AMTX shares dropped 49.3%, trailing the S&P 500 (SPY) return of 16.8%. Over a 5-year period, AMTX fell 91.9%, compared to an 83.0% gain for the S&P 500.

Wall Street analyst ratings for AMTX consist of 3 Strong Buy, 0 Buy, 1 Hold, 0 Sell, and 0 Strong Sell. The mean price target is $13.38, compared to the last close of $1.46. For the fiscal year ending December 31, 2026, consensus estimates project revenue of $259.7M and an EPS of -$0.85. The company beat EPS estimates in 2 of the last 4 quarters, and its next earnings date is November 5, 2026.

This page is an AI-written research summary of Aemetis, Inc. (AMTX). The text was generated on October 30, 2026 from Quotelinks data as of October 16, 2026 (company profile, annual results, latest balance sheet, valuation, price performance and analyst estimates). An automatic check rejects any draft that contains a figure not found in that data. It is not investment advice; verify figures on the linked tabs before making decisions.

Related: AMTX income statement, AMTX balance sheet, AMTX key metrics, AMTX analyst forecast, AMTX chart. See the AMTX stock overview for the latest quote and news.